Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamza Zafar

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 20, 2020
Age-associated changes in 4D flow CMR derived Tricuspid Valvular Flow and Right Ventricular Blood Flow Kinetic EnergyNatasha Barker, Hamza Zafar, Benjamin Fidock, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life frameworkFrances Varian, Rebecca Burney, Charlotte Pearson, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Quantitative Imaging in Medicine and Surgery|April 5, 2021
Left ventricular blood flow kinetic energy is associated with the six-minute walk test and left ventricular remodelling post valvular intervention in aortic stenosisAlaa Elhawaz, Gareth T Archer, Hamza Zafar, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Respirology (Carlton, Vic.)|July 4, 2025
NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote MonitoringCharlotte Durrington, Christian Battersby, Laura Holt, et al.
Pulmonary Circulation|March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologiesFrances Varian, Jennifer Dick, Christian Battersby, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|June 20, 2020
Age-associated changes in 4D flow CMR derived Tricuspid Valvular Flow and Right Ventricular Blood Flow Kinetic EnergyNatasha Barker, Hamza Zafar, Benjamin Fidock, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life frameworkFrances Varian, Rebecca Burney, Charlotte Pearson, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 StudyAlexander M K Rothman, Sofia Villar, Jennifer Middleton, et al.
Quantitative Imaging in Medicine and Surgery|April 5, 2021
Left ventricular blood flow kinetic energy is associated with the six-minute walk test and left ventricular remodelling post valvular intervention in aortic stenosisAlaa Elhawaz, Gareth T Archer, Hamza Zafar, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
Respirology (Carlton, Vic.)|July 4, 2025
NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote MonitoringCharlotte Durrington, Christian Battersby, Laura Holt, et al.
Pulmonary Circulation|March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologiesFrances Varian, Jennifer Dick, Christian Battersby, et al.
Pageof 3